Xiaonian Cao
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- Angiogenesis and VEGF in Cancer 2
- Protein Interaction Studies and Fluorescence Analysis 2
- Oncology 7
- Co-authors
- Junbo Hu (12 shared papers)Xuelai Luo (8 shared papers)Guihua Wang (7 shared papers)Fayong Hu (3 shared papers)Yongdong Feng (4 shared papers)Bo Ai (3 shared papers)Quanfu Huang (3 shared papers)Yongde Liao (3 shared papers)
In The Last Decade
Xiaonian Cao
31 papers receiving 615 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 196
- Molecular Biology 339
- Biochemistry 27
- Oncology 85
- Pulmonary and Respiratory Medicine 73
Countries citing papers authored by Xiaonian Cao
This map shows the geographic impact of Xiaonian Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonian Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonian Cao more than expected).
Fields of papers citing papers by Xiaonian Cao
This network shows the impact of papers produced by Xiaonian Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonian Cao. The network helps show where Xiaonian Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaonian Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 77 | |
| 2 | 2016 | 62 | |
| 3 | 2014 | 53 | |
| 4 | 2012 | 51 | |
| 5 | 2021 | 47 | |
| 6 | 2013 | 32 | |
| 7 | 2017 | 30 | |
| 8 | 2013 | 28 | |
| 9 | 2012 | 25 | |
| 10 | 2016 | 25 | |
| 11 | 2019 | 22 | |
| 12 | 2014 | 17 | |
| 13 | 2015 | 16 | |
| 14 | 2021 | 14 | |
| 15 | 2017 | 14 | |
| 16 | 2020 | 14 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2014 | 8 | |
| 20 | 2016 | 8 |
About Xiaonian Cao
Xiaonian Cao is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 31 papers that have together received 618 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Estrogen and related hormone effects (2 papers), Epigenetics and DNA Methylation (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). The work is most often cited by research in Cancer Research (196 citations), Molecular Biology (339 citations), Biochemistry (27 citations), Oncology (85 citations) and Pulmonary and Respiratory Medicine (73 citations). Xiaonian Cao has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Junbo Hu, Xuelai Luo, Guihua Wang, Fayong Hu, Yongdong Feng, Bo Ai, Quanfu Huang, Yongde Liao, Chuan Li and Xi Yang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Molecular Cancer Therapeutics, Scientific Reports, Microchemical Journal and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.